Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2020.0295
Commentary
|
Modern treatment of colorectal cancer: progress and limitations. |
Prof. Andreas Sendler, MD, PhD.
|
| |
Abstract
Substantial progress in the standardization of colorectal cancer (CRC) treatment, including surgical resection, chemotherapy and radiotherapy for rectal tumors, has been translated into improved oncological outcomes of hundreds of thousands of CRC patients.
However, multiple challenges including clinical prognosis of non-resectable tumors and modest efficacy of targeted drugs in this palliative stage of disease and no approval of these agents in resectable patients have not overcome yet. Controversery in treatment guidelines specifically for rectal cancer and future potential solutions are also discussed Patek Philippe Replica Watches.
(Citation: Gastric & Breast Cancer 2020; 15(1): 37-42)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €35 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 15 January 2020 |
|
